RECURSION PHARMACEUTICALS, INC. Comparison Chart Recursion Pharmaceuticals, Inc.
Equities
RXRX
US75629V1044
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.910 USD | +2.22% |
|
+9.34% | -29.92% |
| 09-03 | Jefferies Cuts Price Target on Recursion Pharmaceuticals to $6 From $8, Maintains Hold Rating | MT |
| 09-03 | Recursion Pharmaceuticals Says REC-994 Phase 2 Trial Shows Safety and Efficacy Trends | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | +2.22% | +9.34% | -29.92% | -19.37% | - | 1.9B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RXRX Stock
- Charts Recursion Pharmaceuticals, Inc.
- Comparison Chart
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition